High value intervention in high cholesterol

The information below relates to the CVD prevention pathway.

  • Maintain and improve systematic collection and audit of data on cholesterol levels, high CVD risk and possible familial hypercholesterolaemia (FH) in practices to support detection and management.
  • Achieve local clinical consensus and establish an integrated pathway for detection and management of raised cholesterol and CVD risk, which includes FH.
    • Identify and investigate possible undiagnosed hypercholesterolaemia and/or FH.
    • Identify and address suboptimal lipid management.
  • Commission local service for FH investigation and cascade testing.
  • Work with practices and local authorities to maximise NHS Health Check uptake.
  • Build local primary care leadership to address unwarranted variation and drive quality improvement in detection and management.
  • Strengthen risk assessment, detection and management through greater use of practice-based and community pharmacists and consider commissioning systematic support specifically for statin adherence from community pharmacy through medicine use reviews (MURs).

Further information

Download the CVD prevention pathway.